Axxam SpA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Axxam SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011791
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Axxam SpA (Axxam) is a partner research organization that provides drug discovery services. The organization offers drug discovery services such as molecular biology, assay development and reagent provision, compound management, hit characterization and profiling and electrophysiology, among others. It has developed proprietary technologies including photina, i-photina and champion technology to develop high throughput screening assays. Axxam offers a pipeline of drug discovery programs in the therapeutic areas of pain, metabolic disorders, Alzheimer’s disease, inflammation and autoimmune diseases. The organization serves pharmaceutical, animal health, crop protection, cosmetics and nutrition companies. It has chemistry laboratories located in Naples. Axxam is headquartered in Milan, Italy.

Axxam SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axxam SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Axxam SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Axxam SpA, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Axxam Acquires QPatch 16X From Sophion Bioscience 10
Venture Financing 11
Acousia Therapeutics Raises USD2.7 Million in Venture Financing 11
Partnerships 12
Axxam Enters into Research Agreement with Sanofi 12
Grunenthal Enters into Agreement with Axxam 13
Axxam Partners with Neomed Institute 14
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 15
Fast Forward And Juvenile Diabetes Research Foundation Extend Co-Development Agreement With Axxam 16
Axxam Enters Into Co-Development Agreement With Polyphor 17
Axxam Forms Joint Venture With InterMed Discovery 18
Axxam SpA – Key Competitors 19
Axxam SpA – Key Employees 20
Axxam SpA – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Axxam SpA, Pharmaceuticals & Healthcare, Key Facts 2
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axxam SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axxam SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axxam SpA, Deals By Therapy Area, 2011 to YTD 2017 8
Axxam SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Axxam Acquires QPatch 16X From Sophion Bioscience 10
Acousia Therapeutics Raises USD2.7 Million in Venture Financing 11
Axxam Enters into Research Agreement with Sanofi 12
Grunenthal Enters into Agreement with Axxam 13
Axxam Partners with Neomed Institute 14
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 15
Fast Forward And Juvenile Diabetes Research Foundation Extend Co-Development Agreement With Axxam 16
Axxam Enters Into Co-Development Agreement With Polyphor 17
Axxam Forms Joint Venture With InterMed Discovery 18
Axxam SpA, Key Competitors 19
Axxam SpA, Key Employees 20
Axxam SpA, Other Locations 21
Axxam SpA, Joint Venture 21

★海外企業調査レポート[Axxam SpA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AvivaSA Emeklilik ve Hayat A.S.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "AvivaSA Emeklilik ve Hayat A.S." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric st …
  • PT Berlian Laju Tanker Tbk (BLTA):企業概要、財務及び戦略的SWOT分析
    Summary PT Berlian Laju Tanker Tbk (Berlian Laju Tanker) is a multinational shipping company. The company provides liquid and gas cargo transportation services. Its main business is the maritime transportation of liquid bulk cargo. The types of cargo carried by the Berlian Laju Tanker’s fleet includ …
  • CASIO COMPUTER CO., LTD:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CASIO COMPUTER CO., LTD Mergers …
  • Eagle Bancorp, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Eagle Bancorp, Inc. Mergers and …
  • Bremer Landesbank Kreditanstalt Oldenburg — Girozentrale:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Bremer Landesbank Kreditanstalt Oldenburg — Girozentrale" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily acces …
  • BAWAG P.S.K. Bank fur Arbeit und Wirtschaft und Osterreichische Postsparkasse Aktiengesellschaft:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BAWAG P.S.K. Bank fur Arbeit un …
  • SMRT Corporation Ltd.:企業の戦略・SWOT・財務分析
    SummarySMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Afren plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Afren plc Mergers and Acquisiti …
  • Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • 3M India Limited (3MINDIA):企業の財務及び戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Waste Management, Inc.:企業のM&A・提携・投資分析
    Waste Management, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Waste Management, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Valcent Products, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Valcent Products, Inc. Mergers …
  • American Greetings Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' American Greetings Corporation …
  • Unid Co., Ltd. (014830):企業財務及び戦略的SWOT分析
    Summary Unid Co., Ltd. (Unid Co) is a chemical company that manufactures and markets board and other chemical products. The company offers chemical division and board division products. Its chemical division manufactures basic inorganic chemical products such as potassium hydroxide, potassium carbon …
  • Admiral Taverns Ltd.:企業の戦略・SWOT・財務分析
    SummaryAdmiral Taverns Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • Marathon Oil Corporation (MRO):企業のM&A・提携動向(石油・ガス分野)
    Summary Marathon Oil Corporation (MRO) is an independent oil and gas company. It explores, produces and markets liquid hydrocarbons and natural gas. The company also markets synthetic crude oil produced from oil sands. MRO conducts oil and gas production activities in North America, Africa and Europ …
  • Evrofarma S.A.:企業の戦略・SWOT・財務分析
    SummaryEvrofarma S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Ohr Pharmaceutical Inc (OHRP):企業財務及び戦略的SWOT分析
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings, Inc. is a biopharmaceutical company that offers development of novel therapeutics and delivery technologies for the treatment of ocular diseases. The company offers products which include squalamine, trodusquemine and SKS technology produc …
  • Pathwork Diagnostics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Pathwork Diagnostics, Inc. Merg …
  • NR Electric Co., Ltd.:企業概要及び戦略的SWOT分析
    NR Electric Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆